famotidine has been researched along with Blood Loss, Postoperative in 5 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 158 patients (155 early gastric cancers and three adenomas) were randomly assigned to the PPI group (omeprazole 20 mg/day) or H(2) RA group (famotidine 40 mg/day) in a prospective randomized controlled trial." | 5.16 | Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. ( Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T, 2012) |
| " Subjects underwent EMR with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate (EMRSH), followed by IV or oral (PO) administration of famotidine at a dosage of 40 mg/day for 2 days." | 2.71 | Comparison of hemostatic effects by route of H2 receptor antagonist administration following endoscopic mucosal resection in patients with neoplastic gastric lesions. ( Ajibe, H; Hanatsuka, K; Hirasawa, T; Kawata, H; Kita, H; Osawa, H; Satoh, K; Satoh, Y; Sugano, K; Sunada, F; Sunada, K; Yamamoto, H; Yoshizawa, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomita, T | 1 |
| Kim, Y | 1 |
| Yamasaki, T | 1 |
| Okugawa, T | 1 |
| Kondo, T | 1 |
| Toyoshima, F | 1 |
| Sakurai, J | 1 |
| Tanaka, J | 1 |
| Morita, T | 1 |
| Oshima, T | 1 |
| Fukui, H | 1 |
| Hori, K | 1 |
| Watari, J | 1 |
| Matsumoto, T | 1 |
| Miwa, H | 1 |
| Muñoz, M | 1 |
| García-Vallejo, JJ | 1 |
| Sempere, JM | 1 |
| Romero, R | 1 |
| Olalla, E | 1 |
| Sebastián, C | 1 |
| Yamaguchi, Y | 1 |
| Katsumi, N | 1 |
| Tauchi, M | 1 |
| Toki, M | 1 |
| Nakamura, K | 1 |
| Aoki, K | 1 |
| Morita, Y | 1 |
| Miura, M | 1 |
| Morozumi, K | 1 |
| Ishida, H | 1 |
| Takahashi, S | 1 |
| Satoh, K | 1 |
| Yamamoto, H | 1 |
| Kawata, H | 1 |
| Osawa, H | 1 |
| Hanatsuka, K | 1 |
| Kita, H | 1 |
| Sunada, K | 1 |
| Hirasawa, T | 1 |
| Yoshizawa, M | 1 |
| Ajibe, H | 1 |
| Satoh, Y | 1 |
| Sunada, F | 1 |
| Sugano, K | 1 |
| Jeong, HK | 1 |
| Park, CH | 1 |
| Jun, CH | 1 |
| Lee, GH | 1 |
| Kim, HI | 1 |
| Kim, HS | 1 |
| Choi, SK | 1 |
| Rew, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study[NCT02081404] | 98 participants (Actual) | Interventional | 2009-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for famotidine and Blood Loss, Postoperative
| Article | Year |
|---|---|
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric | 2012 |
Acute phase response in patients undergoing lumbar spinal surgery: modulation by perioperative treatment with naproxen and famotidine.
Topics: Acute-Phase Reaction; Adult; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Famotidine | 2004 |
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Topics: Aged; Anti-Ulcer Agents; Cost-Benefit Analysis; Endoscopy, Gastrointestinal; Famotidine; Female; Gas | 2005 |
Comparison of hemostatic effects by route of H2 receptor antagonist administration following endoscopic mucosal resection in patients with neoplastic gastric lesions.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Administration, Oral; Aged; Endoscopy, Gastrointestinal; Fam | 2005 |
A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Dissection; Famotidine; Female; Ga | 2007 |